Synonym: Somatotropin
Species: Human
Protein Accession: P05067
Purity: ≥ 95%
Endotoxin Level:
< 1.0 EU per 1 µg of protein
Biological Activity: The ED50 as determined by a cell proliferation assay
using Nb2-11 cells is less than 0.3 ng/ml, corresponding to a specific activity
of > 3.3 × 106 IU/mg.
Expression System: E. coli
Fusion Tag: None
Predicted Molecular Mass: 22 kDa
Formulation: Lyophilized from a 0.2 μm filtered solution of 20 mM PB, 150
mM NaCl, pH 7.0
Reconstitution: Reconstitute with sterile water at 0.1 mg/ml
Storage & Stability: Store lyophilized protein at -20°C. Aliquot
reconstituted protein and store at -20°C. Avoid repeated freeze-thaw cycles.
FAQ
What is Y07601 Recombinant Human GH and how does it benefit livestock in the
feed industry?
Y07601 Recombinant Human Growth Hormone (GH) is a
synthesized form of the naturally occurring growth hormone in humans. In the
feed industry, it can be used to enhance growth rates, improve feed efficiency,
and promote muscle development in livestock. By administering this hormone,
farmers can achieve faster-growing animals, which can reduce the time required
to bring livestock to market. This efficiency can lead to cost savings on feed
and potentially higher profits. Additionally, improved muscle development
translates to higher-quality meat products, which are often more desirable in
the market.
How does Y07601 Recombinant Human GH improve feed efficiency
in livestock?
Feed efficiency is a measure of how well an animal converts
feed into body mass. Y07601 Recombinant Human GH influences this process by
stimulating the production of Insulin-like Growth Factor 1 (IGF-1), which plays
a key role in promoting cell growth and division. This leads to more efficient
nutrient use and greater protein synthesis, resulting in better weight gain with
less feed. Enhanced feed efficiency not only lowers feeding costs but also
reduces the environmental footprint of livestock farming due to less waste and
lower resource consumption.
Is Y07601 Recombinant Human GH safe for use
in animals intended for human consumption?
The safety of Y07601
Recombinant Human GH in livestock has been a subject of extensive research.
Regulatory bodies such as the FDA and EFSA have evaluated its safety based on
rigorous scientific criteria. When used according to prescribed guidelines and
withdrawal periods, the hormone does not remain in the tissues of livestock at
levels that would pose any risk to human health. Regular monitoring and
adherence to regulations ensure that meat products from these animals remain
safe for consumption.
How is Y07601 Recombinant Human GH administered to
livestock and what are the recommended dosages?
Y07601 Recombinant Human
GH is typically administered via injection, which can ensure the precise
delivery of the hormone. The frequency and dosage can vary based on factors such
as the species of livestock, their age, and specific growth targets. It's
crucial to follow veterinary guidance to determine the appropriate regimen.
Over-dosage or improper administration can lead to adverse effects and
diminished returns on investment, while accurate adherence can maximize growth
benefits and feed efficiency.
What are the potential side effects or
risks associated with using Y07601 Recombinant Human GH in
livestock?
While Y07601 Recombinant Human GH offers significant benefits,
there are potential risks and side effects. Overuse can lead to conditions such
as gigantism or acromegaly, characterized by abnormal growth of tissues.
Additionally, there could be metabolic imbalances, increased susceptibility to
diseases, or negative impacts on animal welfare. It's important to follow
veterinary advice and use the hormone responsibly to mitigate these risks.
Continuous monitoring and health assessments are recommended to ensure the
well-being of animals receiving GH treatment.